{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T01:52:15Z","timestamp":1725846735490},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,5,15]],"date-time":"2003-05-15T00:00:00Z","timestamp":1052956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1007\/s00467-003-1162-9","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:27:46Z","timestamp":1576121266000},"page":"714-717","source":"Crossref","is-referenced-by-count":4,"title":["Pamidronate in a girl with chronic renal insufficiency dependent on parenteral nutrition"],"prefix":"10.1007","volume":"18","author":[{"given":"Janet L.","family":"Duke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel K.","family":"Frizzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell W.","family":"Chesney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily B.","family":"Hak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,15]]},"reference":[{"key":"1162_CR1","first-page":"957","volume":"28","author":"Srikanth","year":"1993","unstructured":"Srikanth MS, Ford EG, Isaacs H Jr, Mahour GH (1993) Megacystis microcolon intestinal hypoperistalsis syndrome: late sequelae and possible pathogenesis. J Pediatr Surg 28:957\u2013959","journal-title":"J Pediatr Surg"},{"key":"1162_CR2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0148607192016004386","volume":"16","author":"Koo","year":"1992","unstructured":"Koo WWK (1992) Parenteral nutrition-related bone disease. J Parenter Enter Nutr 16:386\u2013394","journal-title":"J Parenter Enter Nutr"},{"key":"1162_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1542\/peds.97.3.413","volume":"97","author":"Committee","year":"1996","unstructured":"Committee on Nutrition (1996) Aluminum toxicity in infants and children. Pediatrics 97:413\u2013416","journal-title":"Pediatrics"},{"key":"1162_CR4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","volume":"42","author":"Fleisch","year":"1991","unstructured":"Fleisch H (1991) Biphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42:919\u2013944","journal-title":"Drugs"},{"key":"1162_CR5","first-page":"407","volume":"18","author":"Kantrowitz","year":"1975","unstructured":"Kantrowitz FG, Byrne MH, Schiller AL, Krane SM (1975) Clinical and biochemical effects of diphosphonate in Paget's disease of bone (abstract). Arthritis Rheum 18:407","journal-title":"Arthritis Rheum"},{"key":"1162_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(83)91465-4","volume":"1","author":"Bounameaux","year":"1983","unstructured":"Bounameaux HM, Schifferli J, Montani JP, Jung A, Chatelan F (1983) Renal failure associated with intravenous diphosphonate. Lancet 1:471","journal-title":"Lancet"},{"key":"1162_CR7","unstructured":"Tyrrell CJ, Collinson M, Madsen EL, Ford JM, Coleman T (1994) Intravenous pamidronate: infusion rate and safety. Ann Oncol 5 [Suppl 7]:S27\u2013S29"},{"key":"1162_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/08035259850157895","volume":"87","author":"Astrom","year":"1998","unstructured":"Astrom E, Soderhall S (1998) Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paediatr 87:64\u201368","journal-title":"Acta Paediatr"},{"key":"1162_CR9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1651-2227.1994.tb12968.x","volume":"83","author":"Bembi","year":"1994","unstructured":"Bembi B, Agosti E, Boehm P, Nassimbeni G, Zanatta M, Vidoni L (1994) Aminohydroxypropylidene-biphosphonate in the treatment of bone lesions in a case of Gaucher's disease type 3. Acta Paediatr 83:122\u2013124","journal-title":"Acta Paediatr"},{"key":"1162_CR10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-3476(97)70074-X","volume":"131","author":"Bembi","year":"1997","unstructured":"Bembi B, Parma A, Bottega M, Ceschel S, Zanatta M, Martini C, Ciana G (1997) Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr 131:662\u2013665","journal-title":"J Pediatr"},{"key":"1162_CR11","first-page":"261","volume":"157","author":"Fujiwara","year":"1998","unstructured":"Fujiwara I, Ogawa E, Igarashi Y, Ohba M, Asanuma A (1998) Intravenous pamidronate treatment in osteogenesis imperfecta. Eur J Pediatr 157:261\u2013262","journal-title":"Eur J Pediatr"},{"key":"1162_CR12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947\u2013952","journal-title":"N Engl J Med"},{"key":"1162_CR13","first-page":"529","volume":"15","author":"Gonzalez","year":"2001","unstructured":"Gonzalez E, Pavia C, Ros J, Villaronga M, Valls C, Escola J (2001) Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta. J Pediat Endocrinol Metab 15:529\u2013533","journal-title":"J Pediat Endocrinol Metab"},{"key":"1162_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/080352500750028816","volume":"89","author":"Lala","year":"2000","unstructured":"Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, De Sanctis C (2000) Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 89:188\u2013193","journal-title":"Acta Paediatr"},{"key":"1162_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s004670050546","volume":"12","author":"Sellers","year":"1998","unstructured":"Sellers E, Sharma A, Rodd C (1998) The use of pamidronate in three children with renal disease. Pediatr Nephrol 12:778\u2013781","journal-title":"Pediatr Nephrol"},{"key":"1162_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/adc.83.2.143","volume":"83","author":"Shaw","year":"2000","unstructured":"Shaw NJ, Boivin CM, Crabtree NJ (2000) Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child 83:143\u2013145","journal-title":"Arch Dis Child"},{"key":"1162_CR17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mpd.2000.107838","volume":"137","author":"M Zacharin","year":"2000","unstructured":"Zacharin M, Cundy T (2000) Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates J Pediatr 137:410\u2013415","journal-title":"J Pediatr"},{"key":"1162_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1067\/mpd.2000.107836","volume":"137","author":"Zacharin","year":"2000","unstructured":"Zacharin M, O'Sullivan M (2000) Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 137:403\u2013409","journal-title":"J Pediatr"},{"key":"1162_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005792-199707000-00005","volume":"76","author":"C Brumsen","year":"1997","unstructured":"Brumsen C, Hamdy NAT, Papapoulos SE (1997) Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine (Baltimore) 76:266\u2013283","journal-title":"Medicine (Baltimore)"},{"key":"1162_CR20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(85)90848-7","volume":"II","author":"Ralston","year":"1985","unstructured":"Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT (1985) Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids\/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet II:907\u2013910","journal-title":"Lancet"},{"key":"1162_CR21","first-page":"2118","volume":"21","author":"Chakravarty","year":"1994","unstructured":"Chakravarty K, Merry P, Scott DGI (1994) A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone. J Rheumatol 21:2118\u20132121","journal-title":"J Rheumatol"},{"key":"1162_CR22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/BF00869834","volume":"4","author":"Boudailliez","year":"1990","unstructured":"Boudailliez BR, Pautard BJ, Sebert JL, Kremp O, Piussan CX (1990) Leukaemia-associated hypercalcemia in a 10-year-old boy: effectiveness of aminohydroxypropylidene biphosphonate. Pediatr Nephrol 4:510\u2013511","journal-title":"Pediatr Nephrol"},{"key":"1162_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s004310051197","volume":"158","author":"De","year":"1999","unstructured":"De Schepper J, Pont S de, Smitz J, De Coster D, Schots R, Otten J (1999) Metabolic disturbances after a single dose of 30\u00a0mg pamidronate for leukaemia-associated hypercalcemia in a 11-year-old boy. Eur J Pediatr 158:765\u2013768","journal-title":"Eur J Pediatr"},{"key":"1162_CR24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0022-3476(97)80030-3","volume":"130","author":"Kutluk","year":"1997","unstructured":"Kutluk MT, Hazar V, Akyuz C, Varan A, Buyukpamukcu M (1997) Childhood cancer and hypercalcemia: report of a case treated with pamidronate. J Pediatr 130:828\u2013831","journal-title":"J Pediatr"},{"key":"1162_CR25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.102.4.990","volume":"102","author":"Lteif","year":"1998","unstructured":"Lteif AN, Zimmerman D (1998) Bisphosphonates for treatment of childhood hypercalcemia. Pediatrics 102:990\u2013993","journal-title":"Pediatrics"},{"key":"1162_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00007890-199401001-00032","volume":"57","author":"Profumo","year":"1994","unstructured":"Profumo RJ, Reese JC, Foy TM, Garibaldi LR, Kane RE (1994) Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate. Transplantation 57:301\u2013303","journal-title":"Transplantation"},{"key":"1162_CR27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-61-5-952","volume":"61","author":"Hoekman","year":"1985","unstructured":"Hoekman K, Papapoulos SE, Peters ACB, Bijvoet OLM (1985) Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis. J Clin Endocrinol Metab 61:952\u2013956","journal-title":"J Clin Endocrinol Metab"},{"key":"1162_CR28","first-page":"157","volume":"2","author":"Attard","year":"1998","unstructured":"Attard TM, Dhawan A, Kaufman SS, Collier DS, Langnas AN (1998) Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation. Pediatr Transplant 2:157\u2013159","journal-title":"Pediatr Transplant"},{"key":"1162_CR29","first-page":"559","volume":"132","author":"H Kodama","year":"1998","unstructured":"Kodama H, Kubota K, Abe T (1998) Osteogenesis imperfecta: are fractures and growth hormone treatment linked (letter)? J Pediatr 132:559\u2013560","journal-title":"J Pediatr"},{"key":"1162_CR30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1515\/JPEM.1999.12.4.555","volume":"12","author":"Roldan","year":"1999","unstructured":"Roldan EJA, Pasqualini T, Plantalech L (1999) Bisphosphonates in children with osteogenesis imperfecta may improve bone mineralization but not bone strength. Report of two patients. J Pediatr Endocrinol Metab 12:555\u2013559","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1162_CR31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1515\/JPEM.2001.14.5.553","volume":"14","author":"Zumkeller","year":"2001","unstructured":"Zumkeller W, Jassoy A, Lebek S, Nagel M (2001) Clinical, endocrinological and radiological features in a child with McCune-Albright syndrome and pituitary adenoma. J Pediatr Endocrinol Metab 14:553\u2013559","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1162_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/adc.71.3.235","volume":"71","author":"Shaw","year":"1994","unstructured":"Shaw NJ, White CP, Fraser WB, Rosenbloom L (1994) Osteopenia in cerebral palsy. Arch Dis Child 71:235\u2013238","journal-title":"Arch Dis Child"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-003-1162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-003-1162-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-003-1162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T07:03:17Z","timestamp":1665212597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-003-1162-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,15]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1007\/s00467-003-1162-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,15]]}}}